We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 1,883

Hospital walks back study linking aspartame to leukemia
  • Shook Hardy & Bacon LLP
  • USA
  • October 26 2012

Brigham and Women’s Hospital (BWM) has reportedly walked back a recent study claiming to link aspartame with an increased risk of leukemia, non- Hodgkin’s lymphoma (NHL) and other blood-related cancers


FDA issues final rule on mica-based pearlescent pigments in distilled spirits
  • Shook Hardy & Bacon LLP
  • USA
  • October 2 2015

The U.S. Food and Drug Administration (FDA) has issued a final rule allowing "the safe use of mica-based pearlescent pigments prepared from titanium


FDA refuses to re-classify tooth-whitening products as drugs
  • Shook Hardy & Bacon LLP
  • USA
  • May 2 2014

The U.S. Food and Drug Administration (FDA) has denied a Citizen Petition asking the agency to re-categorize tooth-whitening products as drugs


Pelman v. McDonald’s Corp.: no class certification for obese teens
  • Shook Hardy & Bacon LLP
  • USA
  • October 29 2010

A judge from the U.S. Court of International Trade, sitting by designation in a New York federal district court, has determined that the obesity-related claims filed in 2002 against McDonald’s Corp. cannot be pursued as a class action


Lessons Learned From the Intuitive Surgical Lawsuits: The Benefits of Partnering With Independent Educational Firms
  • Shook Hardy & Bacon LLP
  • USA
  • January 30 2017

Though a number of companies manufacture and sell surgical robots in the United States, Intuitive Surgical has been the primary target of product


CalEPA Solicits Info About Nickel, PFOA and PFOS for Potential Listing Under Prop. 65
  • Shook Hardy & Bacon LLP
  • USA
  • February 19 2016

The California Environmental Protection Agency’s (CalEPA’s) Office of Environmental Health Hazard Assessment (OEHHA) has announced the development


Cosmetic Companies Continue to Receive FDA Warning Letters
  • Shook Hardy & Bacon LLP
  • USA
  • October 7 2016

The U.S. Food and Drug Administration (FDA) sent seven warning letters to cosmetics companies in September 2016, continuing the agency's trend of


Michele Simon, “Taking on Big Soda over Taxes: Lessons Learned from Fighting Big Alcohol,” Corporations and Health Watch Newsletter, April 2010
  • Shook Hardy & Bacon LLP
  • USA
  • April 30 2010

"Whether it's the food industry, tobacco, or alcohol, they all use the same talking points and lobbying strategies," opines the Marin Institute's Michele Simon in this April 2010 article that likens "Big Soda" to the alcohol lobby


Landmark Texas Supreme Court decision: learned intermediary doctrine applies in prescription drug cases, no DTC exception
  • Shook Hardy & Bacon LLP
  • USA
  • June 12 2012

Addressing the issue squarely for the first time, the Texas Supreme Court has unanimously adopted the learned intermediary doctrine in the prescription drug context thereby confirming that manufacturers are only obligated to warn doctors of the risks of prescription medicines


Can a Complex Medical Device Require Too Much Training?
  • Shook Hardy & Bacon LLP
  • USA
  • November 24 2015

When filing their complaints, plaintiffs' lawyers usually take the shotgun approach and throw in as many boilerplate allegations as they can think of